Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JAK inhibitor
Pharma
Pfizer plots Litfulo vitiligo filings, pressuring Incyte, AbbVie
Pfizer is headed to regulators with results from a pair of late-stage studies testing its would-be Opzelura rival Litfulo in nonsegmental vitiligo.
Fraiser Kansteiner
Jul 30, 2026 2:15pm
Incyte expects Opzelura to cross $1B in 2026
Jul 29, 2026 10:30am
Durable IBD remission remains an unmet need: survey
Jul 24, 2026 2:07pm
Leo roars onto Netflix with DTC campaign for new eczema cream
Mar 5, 2026 10:45am
FDA signs off on Leo Pharma's chronic hand eczema cream Anzupgo
Jul 24, 2025 8:45am
Sun launches alopecia med Leqselvi after Incyte settlement
Jul 14, 2025 11:21am
